Cargando…
Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
Although the use of tenofovir alafenamide (TAF), a new prodrug of tenofovir, was safe and efficacious in clinical trials, real-world data from multimorbid individuals are scarce. Among 10 persons living with HIV with previous tenofovir disoproxil fumarate–induced nephrotoxicity, renal function remai...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262111/ https://www.ncbi.nlm.nih.gov/pubmed/30515426 http://dx.doi.org/10.1093/ofid/ofy275 |
_version_ | 1783375044114644992 |
---|---|
author | Walti, Laura N Steinrücken, Julia Rauch, Andri Wandeler, Gilles |
author_facet | Walti, Laura N Steinrücken, Julia Rauch, Andri Wandeler, Gilles |
author_sort | Walti, Laura N |
collection | PubMed |
description | Although the use of tenofovir alafenamide (TAF), a new prodrug of tenofovir, was safe and efficacious in clinical trials, real-world data from multimorbid individuals are scarce. Among 10 persons living with HIV with previous tenofovir disoproxil fumarate–induced nephrotoxicity, renal function remained stable, and proteinuria decreased in several patients after the switch to TAF. |
format | Online Article Text |
id | pubmed-6262111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62621112018-12-04 Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity Walti, Laura N Steinrücken, Julia Rauch, Andri Wandeler, Gilles Open Forum Infect Dis Brief Report Although the use of tenofovir alafenamide (TAF), a new prodrug of tenofovir, was safe and efficacious in clinical trials, real-world data from multimorbid individuals are scarce. Among 10 persons living with HIV with previous tenofovir disoproxil fumarate–induced nephrotoxicity, renal function remained stable, and proteinuria decreased in several patients after the switch to TAF. Oxford University Press 2018-10-24 /pmc/articles/PMC6262111/ /pubmed/30515426 http://dx.doi.org/10.1093/ofid/ofy275 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Brief Report Walti, Laura N Steinrücken, Julia Rauch, Andri Wandeler, Gilles Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity |
title | Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity |
title_full | Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity |
title_fullStr | Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity |
title_full_unstemmed | Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity |
title_short | Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity |
title_sort | tenofovir alafenamide in multimorbid hiv-infected patients with prior tenofovir-associated renal toxicity |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262111/ https://www.ncbi.nlm.nih.gov/pubmed/30515426 http://dx.doi.org/10.1093/ofid/ofy275 |
work_keys_str_mv | AT waltilauran tenofoviralafenamideinmultimorbidhivinfectedpatientswithpriortenofovirassociatedrenaltoxicity AT steinruckenjulia tenofoviralafenamideinmultimorbidhivinfectedpatientswithpriortenofovirassociatedrenaltoxicity AT rauchandri tenofoviralafenamideinmultimorbidhivinfectedpatientswithpriortenofovirassociatedrenaltoxicity AT wandelergilles tenofoviralafenamideinmultimorbidhivinfectedpatientswithpriortenofovirassociatedrenaltoxicity |